Cargando…
Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study
BACKGROUND: Unwanted submental fat (SMF) may result in an unattractive chin profile and dissatisfaction with appearance. An approved and rigorously tested non-surgical method for SMF reduction is lacking. OBJECTIVE: To evaluate the efficacy and safety of ATX-101 for the pharmacological reduction of...
Autores principales: | Ascher, B, Hoffmann, K, Walker, P, Lippert, S, Wollina, U, Havlickova, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263247/ https://www.ncbi.nlm.nih.gov/pubmed/24605812 http://dx.doi.org/10.1111/jdv.12377 |
Ejemplares similares
-
Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study
por: Rzany, B, et al.
Publicado: (2014) -
An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
por: Khan, Husnain, et al.
Publicado: (2023) -
Alopecia after injection of ATX-101 for reduction of submental fat
por: Souyoul, Skylar, et al.
Publicado: (2017) -
Abstract: Alopecia in Male Patients Treated with ATX-101 (Deoxycholic Acid) for Submental Fullness
por: Shridharani, Sachin M., et al.
Publicado: (2017) -
Abstract 33: Localized Injection Site Alopecia in Male Patients After Treatment of Submental Fat with ATX-101 (Deoxycholic Acid)
por: Shridharani, Sachin M., et al.
Publicado: (2018)